Potent anti-leukemic activity of a specific cyclin-dependent kinase 9 inhibitor in mouse models of chronic lymphocytic leukemia

Joachim R. Göthert(Essen University Hospital), Jan Dürig(Essen University Hospital)
Oncotarget
May 29, 2018
10.18632/oncotarget.25293
Cited by 5

Related Papers

A Comprehensive Microarray-Based DNA Methylation Study of 367 Hematological Neoplasms
|PLoS ONE|2009|137
High-Dose Cytarabine and Autologous Stem-Cell Transplantation in Mantle Cell Lymphoma: Long-Term Follow-Up of the Randomized Mantle Cell Lymphoma Younger Trial of the European Mantle Cell Lymphoma Network
|Journal of Clinical Oncology|2022|56
Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial
|The Lancet Haematology|2021|53